Insider Trading activities of Somaxon Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Somaxon Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Somaxon Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Somaxon Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is SOMX. The reporting company's CIK number is 1339455.
The total value of stock buying since 2005 is $4,917,266.
The total value of stock sales since 2005 is $36,858,657.
The total value of stock option exercises since 2005 is $949,448.


Go to page:  1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Somaxon Pharmaceuticals, Inc. (SOMX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2013-01 0 $0 412 $1,268 0 $0
2012-09 0 $0 1,367 $396 0 $0
2012-07 0 $0 4,948,698 $1,491,697 0 $0
2012-06 0 $0 141,810 $41,120 0 $0
2012-05 0 $0 1,622,844 $488,634 0 $0
2012-01 0 $0 40,050 $19,103 0 $0
2011-10 0 $0 5,000 $4,260 0 $0
2011-08 0 $0 5,000 $5,560 0 $0
2011-07 0 $0 5,000 $10,634 0 $0
2011-06 11,100 $24,941 0 $0 0 $0
2011-05 0 $0 5,000 $13,245 0 $0
2011-04 0 $0 8,300 $23,423 0 $0
2011-02 0 $0 10,000 $30,099 0 $0
2011-01 0 $0 26,115 $88,742 0 $0
2010-12 0 $0 246,634 $664,378 0 $0
2010-09 2,500 $9,725 14,282 $60,610 3,000 $3,690
2010-08 0 $0 8,000 $36,920 8,000 $9,840
2010-07 0 $0 3,000 $11,970 3,000 $3,690
2010-06 0 $0 24,000 $110,397 9,000 $11,070
2010-04 0 $0 42,553 $319,147 0 $0
2010-03 0 $0 1,936,591 $12,296,142 404,454 $495,078
2010-02 0 $0 206,212 $630,692 177,000 $216,210
2010-01 0 $0 44,674 $116,018 0 $0
2009-12 0 $0 1,445,266 $1,571,382 0 $0
2009-08 0 $0 95,000 $250,800 0 $0
2009-07 4,638,289 $4,870,200 500,000 $1,550,000 0 $0
2009-05 25,000 $12,400 1,000 $370 0 $0
2008-04 0 $0 5,000 $23,544 0 $0
2007-10 0 $0 3,000 $30,510 3,000 $3,600
2007-09 0 $0 4,025 $51,734 4,025 $8,460
2007-08 0 $0 1,000 $10,000 1,000 $1,200
2007-07 0 $0 1,000 $12,320 1,000 $1,200
2007-06 0 $0 65,616 $954,995 6,475 $13,020
2007-05 0 $0 438,057 $7,640,504 45,126 $91,266
2007-04 0 $0 294,338 $5,040,621 39,715 $62,568
2007-03 0 $0 12,275 $149,042 2,275 $5,460
2007-02 0 $0 9,775 $127,022 2,275 $5,460
2007-01 0 $0 12,275 $165,750 2,275 $5,460
2006-12 0 $0 82,676 $1,159,343 4,362 $10,467
2006-11 0 $0 13,397 $197,182 659 $1,580
2006-10 0 $0 27,395 $355,638 54 $129
2006-09 0 $0 85,393 $1,103,445 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Somaxon Pharmaceuticals, Inc. insiders (SOMX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-01-02 Nguyen Tran (SVP and CFO) Sale 412 3.08 1,268
2012-09-05 Emster Kurt Von (Director) Sale 1,367 .29 396
2012-07-09 Mpm Bioventures Iii Gp L.p. (10% Owner) Sale 1,624,574 .31 498,744
2012-07-09 Gadicke Ansbert (10% Owner) Sale 1,624,574 .31 498,744
2012-07-06 Mpm Bioventures Iii Gp L.p. (10% Owner) Sale 671,217 .29 195,324
2012-07-06 Gadicke Ansbert (10% Owner) Sale 671,217 .29 195,324
2012-07-03 Gadicke Ansbert (10% Owner) Sale 98,210 .29 28,480
2012-07-02 Mpm Bioventures Iii Gp L.p. (10% Owner) Sale 178,558 .29 51,781
2012-07-02 Gadicke Ansbert (10% Owner) Sale 80,348 .29 23,300
2012-06-28 Mpm Bioventures Iii Gp L.p. (10% Owner) Sale 19,500 .29 5,655
2012-06-28 Gadicke Ansbert (10% Owner) Sale 19,500 .29 5,655
2012-06-19 Mpm Bioventures Iii Gp L.p. (10% Owner) Sale 12,000 .29 3,479
2012-06-19 Gadicke Ansbert (10% Owner) Sale 12,000 .29 3,479
2012-06-15 Mpm Bioventures Iii Gp L.p. (10% Owner) Sale 1,450 .29 420
2012-06-15 Gadicke Ansbert (10% Owner) Sale 1,450 .29 420
2012-06-06 Mpm Bioventures Iii Gp L.p. (10% Owner) Sale 8,400 .29 2,436
2012-06-06 Gadicke Ansbert (10% Owner) Sale 8,400 .29 2,436
2012-06-05 Mpm Bioventures Iii Gp L.p. (10% Owner) Sale 29,555 .29 8,570
2012-06-05 Gadicke Ansbert (10% Owner) Sale 29,555 .29 8,570
2012-05-31 Wheeler Kurt (10% Owner) Sale 29,850 .30 8,955
2012-05-31 Mpm Bioventures Iii Llc (10% Owner) Sale 29,850 .30 8,955
2012-05-30 Wheeler Kurt (10% Owner) Sale 51,007 .30 15,302
2012-05-30 Mpm Bioventures Iii Llc (10% Owner) Sale 51,007 .30 15,302
2012-05-29 Wheeler Kurt (10% Owner) Sale 15,300 .30 4,620
2012-05-29 Mpm Bioventures Iii Llc (10% Owner) Sale 15,300 .30 4,620
2012-05-25 Wheeler Kurt (10% Owner) Sale 293,015 .30 87,904
2012-05-25 Mpm Bioventures Iii Llc (10% Owner) Sale 293,015 .30 87,904
2012-05-23 Wheeler Kurt (10% Owner) Sale 135,250 .30 40,575
2012-05-23 Mpm Bioventures Iii Llc (10% Owner) Sale 135,250 .30 40,575
2012-05-22 Wheeler Kurt (10% Owner) Sale 287,000 .30 86,961
2012-05-22 Mpm Bioventures Iii Llc (10% Owner) Sale 287,000 .30 86,961
2012-01-03 Nguyen Tran (SVP and CFO) Sale 3,300 .48 1,574
2012-01-03 Dorsey Brian (SVP, Technical Operations) Sale 9,000 .48 4,293
2012-01-03 Onaitis Matthew (SVP, General Counsel) Sale 9,000 .48 4,293
2012-01-03 Pascoe Richard W (President and CEO) Sale 18,750 .48 8,943
2011-10-03 Mast Erle T (Director) Sale 5,000 .85 4,260
2011-08-15 Mast Erle T (Director) Sale 5,000 1.11 5,560
2011-07-01 Mast Erle T (Director) Sale 5,000 2.13 10,634
2011-06-10 Pascoe Richard W (President and CEO) Buy 11,100 2.25 24,941
2011-05-16 Mast Erle T (Director) Sale 5,000 2.65 13,245
2011-04-12 Nguyen Tran (SVP and CFO) Sale 3,300 2.84 9,358
2011-04-01 Mast Erle T (Director) Sale 5,000 2.81 14,065
2011-02-15 Mast Erle T (Director) Sale 10,000 3.01 30,099
2011-01-06 Raser Jeffrey (SVP, Chief Commercial Officer) Sale 16,115 3.50 56,402
2011-01-03 Mast Erle T (Director) Sale 10,000 3.23 32,340
2010-12-02 Emster Kurt Von (Director) Sale 26,000 2.78 72,306
2010-12-01 Dorsey Brian (SVP, Technical Operations) Sale 8,468 2.68 22,728
2010-12-01 Onaitis Matthew (SVP, General Counsel) Sale 8,468 2.68 22,728
2010-12-01 Cobb Terrell (Director) Sale 17,243 2.68 46,262
2010-12-01 Raser Jeffrey (SVP, Chief Commercial Officer) Sale 9,718 2.68 26,063
2010-12-01 Pascoe Richard W (President and CEO) Sale 13,781 2.68 36,974
2010-12-01 Eagle Michael L (Director) Sale 24,900 2.68 66,806
2010-12-01 Wiggans Thomas G (Director) Sale 30,163 2.68 80,927
2010-12-01 Hale David F (Director) Sale 107,893 2.68 289,584
2010-09-22 Cobb Terrell (Director) Sale 11,282 4.24 47,801
2010-09-15 Nguyen Tran (Vice President and CFO) Buy 2,500 3.89 9,725
2010-09-01 Dorsey Brian (SVP, Technical Operations) Sale 3,000 4.27 12,809
2010-09-01 Dorsey Brian (SVP, Technical Operations) Option Ex 3,000 1.23 3,690
2010-08-25 Dorsey Brian (SVP, Technical Operations) Sale 5,000 4.99 24,950
2010-08-25 Dorsey Brian (SVP, Technical Operations) Option Ex 5,000 1.23 6,150
2010-08-10 Dorsey Brian (SVP, Technical Operations) Sale 3,000 3.99 11,970
2010-08-10 Dorsey Brian (SVP, Technical Operations) Option Ex 3,000 1.23 3,690
2010-07-15 Dorsey Brian (SVP, Technical Operations) Sale 3,000 3.99 11,970
2010-07-15 Dorsey Brian (SVP, Technical Operations) Option Ex 3,000 1.23 3,690
2010-06-24 Dorsey Brian (SVP, Technical Operations) Sale 9,000 4.48 40,347
2010-06-24 Dorsey Brian (SVP, Technical Operations) Option Ex 9,000 1.23 11,070
2010-06-24 Raser Jeffrey (SVP, Chief Commercial Officer) Sale 15,000 4.67 70,050
2010-04-30 Emster Kurt Von (Director) Sale 42,553 7.50 319,147
2010-03-18 Dorsey Brian (VP Product Development) Sale 70,500 7.94 560,052
2010-03-18 Dorsey Brian (VP Product Development) Option Ex 58,000 1.23 71,340
2010-03-18 Onaitis Matthew (VP, General Counsel) Sale 32,081 7.53 241,602
2010-03-18 Onaitis Matthew (VP, General Counsel) Option Ex 29,454 1.23 36,228
2010-03-18 Raser Jeffrey (Senior VP, Sales and Marketing) Sale 52,500 8.24 432,757
2010-03-18 Raser Jeffrey (Senior VP, Sales and Marketing) Option Ex 40,000 1.17 46,800
2010-03-18 Pascoe Richard W (President and CEO) Sale 104,510 7.40 773,164
2010-03-18 Pascoe Richard W (President and CEO) Option Ex 100,000 1.23 123,000
2010-03-18 Turner Daniel K Iii (10% Owner) Sale 1,500,000 6.38 9,573,000
2010-03-01 Dorsey Brian (VP Product Development) Sale 23,000 4.01 92,184
2010-03-01 Dorsey Brian (VP Product Development) Option Ex 23,000 1.23 28,290
2010-03-01 Onaitis Matthew (VP, General Counsel) Sale 30,000 4.02 120,480
2010-03-01 Onaitis Matthew (VP, General Counsel) Option Ex 30,000 1.23 36,900
2010-03-01 Raser Jeffrey (Senior VP, Sales and Marketing) Sale 84,000 4.08 342,383
2010-03-01 Raser Jeffrey (Senior VP, Sales and Marketing) Option Ex 84,000 1.23 103,320
2010-03-01 Pascoe Richard W (President and CEO) Sale 40,000 4.01 160,520
2010-03-01 Pascoe Richard W (President and CEO) Option Ex 40,000 1.23 49,200
2010-02-26 Dorsey Brian (VP Product Development) Sale 6,000 3.99 23,940
2010-02-26 Dorsey Brian (VP Product Development) Option Ex 6,000 1.23 7,380
2010-02-05 Dorsey Brian (VP Product Development) Sale 20,712 3.06 63,358
2010-02-05 Dorsey Brian (VP Product Development) Option Ex 11,000 1.23 13,530
2010-02-05 Onaitis Matthew (VP, General Counsel) Sale 60,000 3.02 181,500
2010-02-05 Onaitis Matthew (VP, General Counsel) Option Ex 60,000 1.23 73,800
2010-02-05 Raser Jeffrey (Senior VP, Sales and Marketing) Sale 57,500 3.03 174,282
2010-02-05 Raser Jeffrey (Senior VP, Sales and Marketing) Option Ex 50,000 1.20 60,000
2010-02-05 Pascoe Richard W (President and CEO) Sale 62,000 3.03 187,612
2010-02-05 Pascoe Richard W (President and CEO) Option Ex 50,000 1.23 61,500
2010-01-22 Raser Jeffrey (Senior VP, Sales and Marketing) Sale 44,674 2.60 116,018
2009-12-31 Dorsey Brian (VP Product Development) Sale 5,000 1.07 5,345
2009-12-31 Onaitis Matthew (VP, General Counsel) Sale 5,000 1.07 5,350
2009-12-31 Raser Jeffrey (Senior VP, Sales and Marketing) Sale 5,000 1.07 5,355
2009-12-31 Pascoe Richard W (President and CEO) Sale 8,000 1.07 8,544
2009-12-18 Treu Jesse I (Director) Sale 80,474 1.10 88,521
2009-12-17 Treu Jesse I (Director) Sale 816,292 1.04 848,943
2009-12-14 Treu Jesse I (Director) Sale 35,000 1.15 40,250
2009-12-11 Treu Jesse I (Director) Sale 408,000 1.15 469,199
2009-12-10 Treu Jesse I (Director) Sale 57,500 1.15 66,125
2009-12-08 Raser Jeffrey (Senior VP, Sales and Marketing) Sale 25,000 1.35 33,750
2009-08-26 Lewis Joseph (Other) Sale 95,000 2.64 250,800
2009-07-27 Lewis Joseph (Other) Sale 500,000 3.10 1,550,000
2009-07-08 Brooks Mark J (10% Owner) Buy 510,638 1.05 536,169
2009-07-08 Wheeler Kurt (Director) Buy 1,276,593 1.05 1,340,422
2009-07-08 Mpm Bioventures Iii Llc (10% Owner) Buy 1,276,593 1.05 1,340,422
2009-07-08 Simon Nicholas J Iii (10% Owner) Buy 1,276,593 1.05 1,340,422
2009-07-08 Treu Jesse I (Director) Buy 297,872 1.05 312,765
2009-05-21 Raser Jeffrey (Senior VP, Sales and Marketing) Buy 25,000 .50 12,400
2009-05-01 Dorsey Brian (VP Product Development) Sale 1,000 .37 370
2008-04-15 Jochelson Philip (Senior VP and Chief Medical) Sale 5,000 4.71 23,544
2007-10-01 Mcgilley Meg (VP, CFO, Treasurer) Sale 2,000 10.17 20,340
2007-10-01 Mcgilley Meg (VP, CFO, Treasurer) Option Ex 2,000 1.20 2,400
2007-09-04 Mcgilley Meg (VP, CFO, Treasurer) Sale 1,000 12.27 12,270
2007-09-04 Mcgilley Meg (VP, CFO, Treasurer) Option Ex 1,000 1.20 1,200
2007-09-04 Jochelson Philip (Senior VP and Chief Medical) Sale 3,025 13.05 39,464
2007-09-04 Jochelson Philip (Senior VP and Chief Medical) Option Ex 3,025 2.40 7,260
2007-08-01 Mcgilley Meg (VP, CFO, Treasurer) Sale 1,000 10.00 10,000
2007-08-01 Mcgilley Meg (VP, CFO, Treasurer) Option Ex 1,000 1.20 1,200
2007-07-02 Mcgilley Meg (VP, CFO, Treasurer) Sale 1,000 12.32 12,320
2007-07-02 Mcgilley Meg (VP, CFO, Treasurer) Option Ex 1,000 1.20 1,200
2007-06-13 Cobb Terrell (Director) Sale 5,641 13.65 77,016
2007-06-05 Treu Jesse I (Director) Sale 3,500 14.07 49,245
2007-06-01 Mcgilley Meg (VP, CFO, Treasurer) Sale 4,200 14.80 62,160
2007-06-01 Mcgilley Meg (VP, CFO, Treasurer) Option Ex 4,200 1.80 7,560
2007-06-01 Jochelson Philip (Senior VP and Chief Medical) Sale 2,275 14.67 33,374
2007-06-01 Jochelson Philip (Senior VP and Chief Medical) Option Ex 2,275 2.40 5,460
2007-06-01 Garner Cam L (Director) Sale 50,000 14.66 733,200
2007-05-31 Dorsey Brian (VP Product Development) Sale 1,500 15.00 22,500
2007-05-31 Dorsey Brian (VP Product Development) Option Ex 1,500 2.70 4,050
2007-05-17 Treu Jesse I (Director) Sale 4,297 14.50 62,306
2007-05-15 Glenn Scott L (Director) Option Ex 19,166 2.80 53,664
2007-05-14 Emster Kurt Von (Director) Sale 36,300 14.80 537,385
2007-05-11 Cohen Kenneth M (President and CEO) Option Ex 15,000 1.20 18,000
2007-05-11 Emster Kurt Von (Director) Sale 32,060 14.62 468,845
2007-05-10 Emster Kurt Von (Director) Sale 25,000 15.65 391,325
2007-05-08 Wheeler Kurt (Director) Sale 72,900 18.23 1,329,258
2007-05-08 Mpm Bioventures Iii Llc (10% Owner) Sale 72,900 18.23 1,329,258
2007-05-08 Simon Nicholas J Iii (10% Owner) Sale 72,900 18.23 1,329,258
2007-05-07 Raser Jeffrey (Senior VP, Sales and Marketing) Sale 1,000 17.85 17,850
2007-05-04 Wheeler Kurt (Director) Sale 3,800 18.00 68,400
2007-05-04 Mpm Bioventures Iii Llc (10% Owner) Sale 3,800 18.00 68,400
2007-05-04 Simon Nicholas J Iii (10% Owner) Sale 3,800 18.00 68,400
2007-05-02 Wheeler Kurt (Director) Sale 675 18.03 12,170
2007-05-02 Mpm Bioventures Iii Llc (10% Owner) Sale 675 18.03 12,170
Go to page:  1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of SOMX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Somaxon Pharmaceuticals, Inc. (symbol SOMX, CIK number 1339455) see the Securities and Exchange Commission (SEC) website.